Comparative Study
Looking at US versus European exit opportunities
- PMID: 16302294
Item in Clipboard
Comparative Study
Looking at US versus European exit opportunities
Nat Biotechnol.
2005 Oct.
No abstract available
Similar articles
-
The rise of European venture capital for biotechnology.Nat Biotechnol. 2003 Nov;21(11):1287-91. doi: 10.1038/nbt1103-1287. Nat Biotechnol. 2003. PMID: 14595356 No abstract available.
-
Biotech IPOs--flop or pop?Nat Biotechnol. 2004 Aug;22(8):949. doi: 10.1038/nbt0804-949. Nat Biotechnol. 2004. PMID: 15286641 No abstract available.
-
Mind the (biomedical funding) gap.Nat Biotechnol. 2005 Oct;23(10):1217-8. doi: 10.1038/nbt1005-1217. Nat Biotechnol. 2005. PMID: 16211055 No abstract available.
-
Hurdles and opportunities for a venture capitalist investing in therapies for orphan retinal diseases.Retina. 2005 Dec;25(8 Suppl):S105-S108. doi: 10.1097/00006982-200512001-00054. Retina. 2005. PMID: 16374312 Review. No abstract available.
-
How the EU can fund your company.Nat Biotechnol. 2007 Jan;25(1):21-4. doi: 10.1038/bioent914. Nat Biotechnol. 2007. PMID: 17294566 Review. No abstract available.